Showing results (21-30 of 46) with videos related to
Sort By:
Pageof 5
Journal of Controlled Release : Official Journal of the Controlled Release Society|July 6, 2015
Exosome mediated communication within the tumor microenvironmentLara Milane, Amit Singh, George Mattheolabakis, et al.International Journal of Pharmaceutics|October 31, 2009
Transcutaneous delivery of a nanoencapsulated antigen: induction of immune responsesGeorge Mattheolabakis, George Lagoumintzis, Zoi Panagi, et al.International Journal of Nanomedicine|September 28, 2020
Nucleic Acid Delivery with α-Tocopherol-Polyethyleneimine-Polyethylene Glycol Nanocarrier SystemA K M Nawshad Hossian, Seetharama D Jois, Subash C Jonnalagadda, et al.European Journal of Medicinal Chemistry|March 5, 2021
A grafted peptidomimetic for EGFR heterodimerization inhibition: Implications in NSCLC modelsSitanshu S Singh, George Mattheolabakis, Xin Gu, et al.International Journal of Oncology|June 29, 2013
Curcumin enhances the lung cancer chemopreventive efficacy of phospho-sulindac by improving its pharmacokineticsKa-Wing Cheng, Chi C Wong, George Mattheolabakis, et al.Pharmaceutical Research|March 14, 2013
Topically applied phospho-sulindac hydrogel is efficacious and safe in the treatment of experimental arthritis in ratsGeorge Mattheolabakis, Gerardo G Mackenzie, Liqun Huang, et al.Nanoscale|July 21, 2010
Preparation, stability and cytocompatibility of magnetic/PLA-PEG hybridsAristides Bakandritsos, George Mattheolabakis, Radek Zboril, et al.International Journal of Molecular Sciences|April 27, 2024
Stable Dual miR-143 and miR-506 Upregulation Inhibits Proliferation and Cell Cycle ProgressionArchana Shrestha, Behnaz Lahooti, A K M Nawshad Hossian, et al.Scientific Reports|July 14, 2018
Multipronged activity of combinatorial miR-143 and miR-506 inhibits Lung Cancer cell cycle progression and angiogenesis in vitroA K M Nawshad Hossian, Md Sanaullah Sajib, Paul E Tullar, et al.Small (Weinheim an Der Bergstrasse, Germany)|July 20, 2016
Mixed Nanosized Polymeric Micelles as Promoter of Doxorubicin and miRNA-34a Co-Delivery Triggered by Dual Stimuli in Tumor TissueGiuseppina Salzano, Daniel F Costa, Can Sarisozen, et al.Pageof 5